Impact of comorbidities on physical function and survival of middle-aged, as compared to older, individuals with cancer
Author:
Funder
European Union / Interreg IV Grensregio Vlaanderen - Nederland
Kom op tegen Kanker
Publisher
Springer Science and Business Media LLC
Subject
Oncology
Link
https://link.springer.com/content/pdf/10.1007/s00520-021-06567-1.pdf
Reference26 articles.
1. Sarfati D, Koczwara B, Jackson C (2016) The impact of comorbidity on cancer and its treatment. CA Cancer J Clin 66(4):337–350. https://doi.org/10.3322/caac.21342
2. Ng HS, Koczwara B, Roder D, Vitry A (2018) Changes in the prevalence of comorbidity in the Australian population with cancer, 2007–2014. Cancer Epidemiol 54:56–62. https://doi.org/10.1016/j.canep.2018.03.010
3. Ritchie CS, Kvale E, Fisch MJ (2011) Multimorbidity: an Issue of Growing Importance for Oncologists. J Oncol Pract 7(6):371–374. https://doi.org/10.1200/JOP.2011.000460
4. Jack E, Maskrey N, Byng R (2018) SHERPA: a new model for clinical decision making in patients with multimorbidity. Lancet 392:1397–1399. https://doi.org/10.1016/S0140-6736(18)31371-0
5. Webster S, Lawn S, Chan R et al (2020) The role of comorbidity assessment in guiding treatment decision-making for women with early breast cancer: a systematic literature review. Support Care Cancer 28:1041–1050. https://doi.org/10.1007/s00520-019-05218-w
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Hospital and long-term periods of myocardial infarction in comorbid men and women under 60 years;Ateroscleroz;2023-12-15
2. Clinical course and features of soft tissue sarcomas in geriatric patients: a single-center experience;Journal of International Medical Research;2023-03
3. Development and validation of a nomogram to predict the risk of potentially inappropriate medication use in older lung cancer outpatients with multimorbidity;Expert Opinion on Drug Safety;2023-02-22
4. Prevalence of polypharmacy and potentially inappropriate medication use in older lung cancer patients: A systematic review and meta-analysis;Frontiers in Pharmacology;2022-12-16
5. Impact of the expert consensus on polypharmacy and potentially inappropriate medication use in elderly lung cancer outpatients with multimorbidity: An interrupted time series analysis, 2016–2021;Frontiers in Pharmacology;2022-10-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3